In contrast to data gathered in breast cancer cells, the cell cycle profiles, proliferation rates, and the adhesion abilities were not different between CD24‐deficient and parental cells, but the migratory capacity trended to be increased (Fig. 3C–F) [87, 88]. This evidence concerns the gene CD24 and breast cancer.